21.2 C
New York
Thursday, June 18, 2026

Tag: chairman

“Premium Pet Supplies Expo 2026” Officially Opens

Exotic Pets Steal the Spotlight with Debut Reptilia Carnival and Live Insect Exhibition Featuring Over 50 SpeciesHONG KONG, June 5, 2026 /PRNewswire/ -- Organized...

Gift of Life Marrow Registry Gala Celebrates First-Time Meetings Between Two Transplant Recipients and Their Lifesaving Donors

Gift of Life Marrow Registry hosted its annual NYC Gala, where two transplant recipients, including a 13-year-old boy, were united with their donors.

Global Fashion CEOs Converge in Milan as Industry Enters a New Strategic Cycle

Geopolitics, capital discipline, emerging market growth, retail reinvention and AI shaped the agenda at the 2026 RLC Fashion SummitMILAN, June 5, 2026 /PRNewswire/ --...

STEALTHGAS INC. Reports First Quarter 2026 Financial And Operating Results

ATHENS, Greece, June 05, 2026 (GLOBE NEWSWIRE) -- STEALTHGAS INC. (NASDAQ: GASS), a ship-owning company serving the liquefied petroleum gas (LPG) sector of the international shipping industry, announced today its unaudited financial and operating results for the first quarter ended March 31, 2026.

Eos Energy Stockholders Approve All Proposals at 2026 Annual Meeting

Increased share authorization provides the capital structure flexibility to fund the planned Frontier Power USA Investment
Increased share authorization provides the capital structure flexibility to fund the planned Frontier Power USA Investment

Blink Charging Announces Strategic Sale of Envoy to Blade Ranger to Advance Focus on Core Charging Infrastructure

Transaction underscores shift to a focused, operator-led model centered on reliability, 
utilization, and financial performance

G-III Apparel Group, LTD. Reports First Quarter Fiscal 2027 Results and Raises Earnings Guidance

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (NasdaqGS: GIII) (“G-III” or the “Company”) today reported results for the first quarter of fiscal year 2027, ended April 30, 2026.

China’s Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and...

COMPUTEX 2026 Concludes Successfully as Global Innovation Shapes a New AI Ecosystem

TAIPEI, June 5, 2026 /PRNewswire/ -- COMPUTEX 2026, one of the world's leading exhibitions for AIoT and startup innovation, concluded successfully today. Under the...

China’s Leading Innovative Drug Developer for Allergic and Autoimmune Diseases LongBio Pharma Lists on Hong Kong Stock Exchange

SHANGHAI, June 5, 2026 /PRNewswire/ -- LongBio Pharma, a portfolio company of Qiming Venture Partners and a leading innovative drug developer for allergic and...

Ferretti S.p.A. Shareholders Elect New Board of Directors at Annual General Meeting; FIH and Weichai Group Reaffirm Full Support for the Company’s Future Development

HONG KONG and MILAN, June 5, 2026 /PRNewswire/ -- The Annual General Meeting of Ferretti S.p.A. (HKEX stock code: 9638; Euronext Milan stock code: YACHT)...

UTGL Donates HK$650,000 to Advance Anti-Aging, Cardiovascular Health and Healthy Longevity Through Corporate Social Responsibility and Clinical Research

HONG KONG, June 5, 2026 /PRNewswire/ -- UniTrust Global Limited | UTGL announced a donation of HK$650,000 to Prime Healthcare Medical Services Limited in...

Boralex Announces Shareholder Approval of the Arrangement with Brookfield and La Caisse

MONTRÉAL, June 04, 2026 (GLOBE NEWSWIRE) -- Boralex Inc. ("Boralex" or the "Corporation") (TSX: BLX) is pleased to announce that its shareholders have approved, at the annual and special meeting held on June 4, 2026 (the "Meeting"), a special resolution (the "Arrangement Resolution") approving the statutory plan of arrangement for the acquisition by BIF Thunder Holdings Inc., a newly-formed entity to be jointly owned by Brookfield Infrastructure Fund V and/or its affiliates (collectively, "Brookfield") and Caisse de dépôt et placement du Québec ("La Caisse"), of all the issued and outstanding Class A common shares of Boralex (the "Shares") at $37.25 in cash per Share (the "Arrangement").

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option

Offering was led by B Group Capital with significant participation from, among others, Columbia Threadneedle Investments, Corbets Capital, Venture 76, and Mossrock Capital
Offering was led by B Group Capital with significant participation from, among others, Columbia Threadneedle Investments, Corbets Capital, Venture 76, and Mossrock Capital

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsChairman